Laurion Capital Management »

Leap Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $216k 709k 0.31
2024-12-31 $2.0M 709k 2.88
2024-09-30 $1.8M 709k 2.57
2024-06-30 $1.4M 709k 1.96

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Leap Therapeutics

Gilead Sciences
Acadian Asset Management
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
Key Client Fiduciary Advisors
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics